NovoLet® Surveillance Study on Using Human Insulin System in Indonesia

NCT01492153 · clinicaltrials.gov ↗

COMPLETED

Status

1981

Enrollment

INDUSTRY

Sponsor class

Conditions

Diabetes
Diabetes Mellitus, Type 1
Diabetes Mellitus, Type 2

Interventions

DRUG: biphasic human insulin
DRUG: isophane human insulin
DRUG: human soluble insulin

Sponsor

Novo Nordisk A/S